Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Thomas Evely

Sports Medicine Birmingham, AL Doctor of Osteopathy

NPI 1205217577 CMS profile 1400039

619 19Th St S, Birmingham, AL 35249

Open in the dashboard

General payments

$33,601

179 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Evely of Birmingham, AL is reported in the CMS Open Payments database as having received $33,601 across 179 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,985 33
2024 General $4,342 40
2023 General $7,153 64
2022 General $459 11
2021 General $12,662 30
2020 General $5,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Evely
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Thomas Evely were reported at $3,985. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Thomas Evely Sports Medicine median Middle half National median
2019 $0 $1,176 $199–$4,249 $163
2020 $5,000 $708 $96–$2,890 $114
2021 $12,662 $1,213 $152–$3,994 $132
2022 $459 $1,230 $159–$3,998 $149
2023 $7,153 $584 $146–$2,836 $160
2024 $4,342 $628 $163–$3,168 $164
2025 $3,985 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Smith+Nephew, Inc. $10,266 11 payments
  2. Arthrex, Inc. $6,288 42 payments
  3. Zimmer Biomet Holdings, Inc. $5,108 40 payments
  4. Shoulder Innovations, Inc. $3,480 20 payments
  5. Exactech, Inc. $2,424 14 payments
  6. Prime Surgical, LLC $1,580 15 payments
  7. Gentleman Orthopedic Solutions $1,200 1 payment
  8. Encore Medical, LP $980 5 payments
  9. Linvatec Corporation $507 4 payments
  10. LinkBio Corp $506 2 payments
  11. Other $1,262 25 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Education $14,950 7 payments
  2. Food and Beverage $9,414 141 payments
  3. Travel and Lodging $9,174 29 payments
  4. Gift $63 2 payments
Products named General payments · program years 2020–2025
  1. Comprehensive Shoulder System $3,745 23 payments
  2. InSet System $3,480 20 payments
  3. EQUINOXE Orthopaedic $1,284 2 payments
  4. DJO SURGICAL Joint Implants $720 3 payments
  5. DJO SURGICAL Joint Implants $578 4 payments
  6. BIOBRACE 23MM $507 4 payments
  7. Equinoxe Orthopaedic $460 7 payments
  8. DJO SURGICAL Joint Implants $402 1 payment
  9. DJO SURGICAL Joint Implants $318 2 payments
  10. EQUINOXE Orthopaedic $306 2 payments
  11. Other $3,217 69 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record